Article
Paradigm shift in the management of metastatic Non-small Cell Lung Cancer
2021-02-18
Abstract excerpt
<h4>Background: </h4> Lung cancer is one of the leading causes of cancer mortality in the US. The use of precision medicine in the past 10 years has significantly changed the therapeutic landscape of lung cancer. Management of advanced non-small cell lung cancer (NSCLC) has transitioned from a chemotherapeutic approach to targeted treatments and immunotherapeutic agents. Several tyrosine kinase inhibitors (TKIs) h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 094f05ce-3248-53f2-987f-af06b619d8f8
- DOI
- 10.22541/au.161358458.83540275/v2
